Personality and Cognition across Cognitive-Behavioural Therapy versus Antidepressant Medication for Major Depressive Disorder: Temporal Dynamics and Associations with Long-term Outcomes

认知行为疗法与抗抑郁药物治疗重度抑郁症的人格和认知：时间动态及其与长期结果的关联

• 批准号: 318252
• 负责人: Gralnick Tara M
• 金额: $ 10.93万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2014
• 资助国家: 加拿大
• 起止时间: 2014-11-01 至 2017-11-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=318252&lang=en
• 关键词: Antidepressant Medication; Cognitive Content; Cognitive Processing; Cognitive-Behavioural Therapy; Long-Term Outcomes; Major Depressive Disorder; Personality

Major depressive disorder (MDD) is a pressing public health concern, affecting approximately 3.2 million Canadians, and resulting in immense personal and functional difficulties. Despite the development of empirically validated treatments (e.g., cognitive

严重抑郁障碍(MDD)是一个紧迫的公共卫生问题，影响着大约320万加拿大人，并导致巨大的个人和功能困难。尽管开发了经验性验证的治疗方法(例如，认知